Vantrexa · NSCLC · Italy · Thoracic medical oncologist · captured by Mei Tanaka on 05 Jun 2026 · reviewed by Dr. Marcus Lindqvist on 09 Jun 2026
Verbatim as captured; never edited
Thoracic medical oncologist at Policlinico Gemelli raised infusion-reaction management during a scientific exchange. They requested supporting literature and a follow-up discussion.
Human-approved by Dr. Marcus Lindqvist on 09 Jun 2026
Infusion-reaction management: interest in collaboration reported by thoracic medical oncologist (IT).
No AI assistance
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 5 | 20% | 20.0 |
| Scientific importance | 3 | 15% | 9.0 |
| Urgency | 2 | 15% | 6.0 |
| Novelty | 1 | 10% | 2.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 4 | 5% | 4.0 |
| Breadth of occurrence | 1 | 5% | 1.0 |
| Total | Medium 52 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
05 Jun 2026 · Dr. Sven Abbott, Policlinico Gemelli · MSL Mei Tanaka
Insight
Reviewed 09 Jun 2026 by Dr. Marcus Lindqvist
Action
Initiative
Decision
Outcome
Closure